| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 6874081
[patent_doc_number] => 20030194378
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-16
[patent_title] => 'Novel aerosol formulation containing a polar fluorinated molecule'
[patent_app_type] => new
[patent_app_number] => 10/332568
[patent_app_country] => US
[patent_app_date] => 2003-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 10987
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0194/20030194378.pdf
[firstpage_image] =>[orig_patent_app_number] => 10332568
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/332568 | Novel aerosol formulation containing a polar fluorinated molecule | Jan 8, 2003 | Abandoned |
Array
(
[id] => 6710447
[patent_doc_number] => 20030170196
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-11
[patent_title] => 'Dermatological/cosmetic gels comprising at least one retinoid and benzoyl peroxide'
[patent_app_type] => new
[patent_app_number] => 10/326389
[patent_app_country] => US
[patent_app_date] => 2002-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6040
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20030170196.pdf
[firstpage_image] =>[orig_patent_app_number] => 10326389
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/326389 | Gel composition for once-daily treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt | Dec 22, 2002 | Issued |
Array
(
[id] => 7314280
[patent_doc_number] => 20040033982
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-19
[patent_title] => 'Viral inhibition by n-docosanol'
[patent_app_type] => new
[patent_app_number] => 10/312321
[patent_app_country] => US
[patent_app_date] => 2002-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 25754
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0033/20040033982.pdf
[firstpage_image] =>[orig_patent_app_number] => 10312321
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/312321 | Viral inhibition by n-docosanol | Dec 19, 2002 | Abandoned |
Array
(
[id] => 7361801
[patent_doc_number] => 20040014692
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-22
[patent_title] => 'Compositions incorporating(-)-hydroxycitric acid, chromium, and gymnemic acid, and related methods for promoting healthy body weight and improving related health factors'
[patent_app_type] => new
[patent_app_number] => 10/325675
[patent_app_country] => US
[patent_app_date] => 2002-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5917
[patent_no_of_claims] => 102
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20040014692.pdf
[firstpage_image] =>[orig_patent_app_number] => 10325675
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/325675 | Compositions incorporating(-)-hydroxycitric acid, chromium, and gymnemic acid, and related methods for promoting healthy body weight and improving related health factors | Dec 19, 2002 | Abandoned |
Array
(
[id] => 7111850
[patent_doc_number] => 20050209306
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-22
[patent_title] => 'Crystalline [R-(R*,R*)]-2-(4-fluorophenyI)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl- 4-[(phenylamino)carbonyl]-1H-pyrrole-heptanoic acid calcium salt (2:1)'
[patent_app_type] => utility
[patent_app_number] => 10/316822
[patent_app_country] => US
[patent_app_date] => 2002-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4400
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20050209306.pdf
[firstpage_image] =>[orig_patent_app_number] => 10316822
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/316822 | Crystalline [R-(R*,R*)]-2-(4-fluorophenyI)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl- 4-[(phenylamino)carbonyl]-1H-pyrrole-heptanoic acid calcium salt (2:1) | Dec 10, 2002 | Abandoned |
Array
(
[id] => 6905171
[patent_doc_number] => 20050100566
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-12
[patent_title] => 'Gel composition for external use, pad materials and pad materials to be packed in blister containers'
[patent_app_type] => utility
[patent_app_number] => 10/498214
[patent_app_country] => US
[patent_app_date] => 2002-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 13357
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0100/20050100566.pdf
[firstpage_image] =>[orig_patent_app_number] => 10498214
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/498214 | Gel composition for external use, pad materials and pad materials to be packed in blister containers | Dec 10, 2002 | Abandoned |
Array
(
[id] => 459099
[patent_doc_number] => 07241451
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2007-07-10
[patent_title] => 'Composition for reducing the appearance of scars'
[patent_app_type] => utility
[patent_app_number] => 10/314580
[patent_app_country] => US
[patent_app_date] => 2002-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 3
[patent_no_of_words] => 2068
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/241/07241451.pdf
[firstpage_image] =>[orig_patent_app_number] => 10314580
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/314580 | Composition for reducing the appearance of scars | Dec 8, 2002 | Issued |
Array
(
[id] => 7288568
[patent_doc_number] => 20040109832
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-10
[patent_title] => 'Di-substituted resorcinols as skin lightening agents'
[patent_app_type] => new
[patent_app_number] => 10/314627
[patent_app_country] => US
[patent_app_date] => 2002-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5627
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0109/20040109832.pdf
[firstpage_image] =>[orig_patent_app_number] => 10314627
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/314627 | Di-substituted resorcinols as skin lightening agents | Dec 8, 2002 | Abandoned |
| 10/297709 | Hand Treatment Lotion | Dec 5, 2002 | Abandoned |
Array
(
[id] => 5777436
[patent_doc_number] => 20060106076
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-18
[patent_title] => 'Compositions and methods for the non-invasive treatment of uterine fibroid cells'
[patent_app_type] => utility
[patent_app_number] => 10/313925
[patent_app_country] => US
[patent_app_date] => 2002-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6206
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0106/20060106076.pdf
[firstpage_image] =>[orig_patent_app_number] => 10313925
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/313925 | Compositions and methods for the non-invasive treatment of uterine fibroid cells | Dec 5, 2002 | Abandoned |
Array
(
[id] => 6855753
[patent_doc_number] => 20030129254
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-10
[patent_title] => 'Bactericidal/disinfectant peracetic and acid composition'
[patent_app_type] => new
[patent_app_number] => 10/310199
[patent_app_country] => US
[patent_app_date] => 2002-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6694
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20030129254.pdf
[firstpage_image] =>[orig_patent_app_number] => 10310199
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/310199 | Bactericidal/disinfectant peracetic and acid composition | Dec 3, 2002 | Abandoned |
Array
(
[id] => 6740751
[patent_doc_number] => 20030158120
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-21
[patent_title] => 'Combination product comprising melagatran and a factor xa inhibitor'
[patent_app_type] => new
[patent_app_number] => 10/297537
[patent_app_country] => US
[patent_app_date] => 2002-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5574
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20030158120.pdf
[firstpage_image] =>[orig_patent_app_number] => 10297537
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/297537 | Combination product comprising melagatran and a factor xa inhibitor | Dec 3, 2002 | Abandoned |
Array
(
[id] => 6760714
[patent_doc_number] => 20030124075
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-03
[patent_title] => 'Use of a composition containing at least one oxidation-sensitive hydrophilic active principle and at least one N-vinylimidazole polymer or copolymer'
[patent_app_type] => new
[patent_app_number] => 10/304861
[patent_app_country] => US
[patent_app_date] => 2002-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6333
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20030124075.pdf
[firstpage_image] =>[orig_patent_app_number] => 10304861
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/304861 | Use of a composition containing at least one oxidation-sensitive hydrophilic active principle and at least one N-vinylimidazole polymer or copolymer | Nov 26, 2002 | Abandoned |
Array
(
[id] => 6762016
[patent_doc_number] => 20030125378
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-03
[patent_title] => 'Composition containing at least one oxidation-sensitive hydrophilic active principle and at least one N-vinylimidazole polymer or copolymer useful to prevent and/or treat cutaneous signs of intrinsic ageing'
[patent_app_type] => new
[patent_app_number] => 10/304862
[patent_app_country] => US
[patent_app_date] => 2002-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7385
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0125/20030125378.pdf
[firstpage_image] =>[orig_patent_app_number] => 10304862
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/304862 | Composition containing at least one oxidation-sensitive hydrophilic active principle and at least one N-vinylimidazole polymer or copolymer useful to prevent and/or treat cutaneous signs of intrinsic ageing | Nov 26, 2002 | Abandoned |
Array
(
[id] => 6658089
[patent_doc_number] => 20030078245
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-24
[patent_title] => 'Progestogen-anti-progestogen regimens'
[patent_app_type] => new
[patent_app_number] => 10/303436
[patent_app_country] => US
[patent_app_date] => 2002-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2547
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0078/20030078245.pdf
[firstpage_image] =>[orig_patent_app_number] => 10303436
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/303436 | Progestogen-anti-progestogen regimens | Nov 24, 2002 | Abandoned |
Array
(
[id] => 6796440
[patent_doc_number] => 20030175314
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-18
[patent_title] => 'Pharmaceutical composition for dermal application'
[patent_app_type] => new
[patent_app_number] => 10/295945
[patent_app_country] => US
[patent_app_date] => 2002-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3649
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20030175314.pdf
[firstpage_image] =>[orig_patent_app_number] => 10295945
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/295945 | Pharmaceutical composition for dermal application | Nov 17, 2002 | Abandoned |
Array
(
[id] => 6710540
[patent_doc_number] => 20030170289
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-11
[patent_title] => 'Injectable depot compositions and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/295527
[patent_app_country] => US
[patent_app_date] => 2002-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 18696
[patent_no_of_claims] => 112
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20030170289.pdf
[firstpage_image] =>[orig_patent_app_number] => 10295527
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/295527 | Injectable depot compositions and uses thereof | Nov 13, 2002 | Abandoned |
Array
(
[id] => 6911882
[patent_doc_number] => 20050175640
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-11
[patent_title] => 'External medicine for treating dermatitis'
[patent_app_type] => utility
[patent_app_number] => 10/516657
[patent_app_country] => US
[patent_app_date] => 2002-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3157
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20050175640.pdf
[firstpage_image] =>[orig_patent_app_number] => 10516657
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/516657 | External medicine for treating dermatitis | Nov 11, 2002 | Issued |
Array
(
[id] => 1046509
[patent_doc_number] => 06863902
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-03-08
[patent_title] => 'Immediate release eplerenone compositions'
[patent_app_type] => utility
[patent_app_number] => 10/289025
[patent_app_country] => US
[patent_app_date] => 2002-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 33086
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/863/06863902.pdf
[firstpage_image] =>[orig_patent_app_number] => 10289025
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/289025 | Immediate release eplerenone compositions | Nov 5, 2002 | Issued |
Array
(
[id] => 6696316
[patent_doc_number] => 20030108510
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-12
[patent_title] => 'Skin cream stimulating the surface bloodstream'
[patent_app_type] => new
[patent_app_number] => 10/182129
[patent_app_country] => US
[patent_app_date] => 2002-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1070
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0108/20030108510.pdf
[firstpage_image] =>[orig_patent_app_number] => 10182129
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/182129 | Skin cream stimulating the surface bloodstream | Oct 31, 2002 | Abandoned |